Dasatinib compared to imatinib in patients with newly diagnosed chronic-phase chronic myelogenous leukemia (CML-CP): results from the randomized phase 3 dasision tria

• Authors: BACCARANI M.; SHAH N.; KANTARIJAN H.; CORTES J.; SHAH S.; AYALA M.; MOIRAGHI B.; MAYER Jiří; BRADLEY-GARELIK M.; ZHU C.; HOCHHAUS A.
• Year of publication: 2010
• Type: Conference abstract
• MU Faculty or unit: Faculty of Medicine